Readmission in COPD Patients: Should We Consider It a Marker of Quality of Care or a Marker of a More Severe Disease With a Worse Prognosis?

European Respiratory Journal - United Kingdom
doi 10.1183/13993003.00885-2016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Hyponatraemia: More Than Just a Marker of Disease Severity?

Nature Reviews Nephrology
Nephrology
2013English

Dengue NS1 Antigen as a Marker of Severe Clinical Disease

BMC Infectious Diseases
Infectious Diseases
2014English

ASCA: Genetic Marker, Predictor of Disease, or Marker of a Response to an Environmental Antigen?

Gut
Gastroenterology
2005English

Ambulatory Blood Pressure Monitoring of Patients With Heart Failure: A New Prognosis Marker

Arquivos Brasileiros de Cardiologia
Cardiovascular MedicineCardiology
2002English

Concomitant Monitoring ofWT1andFLT3-ITDexpression inFLT3-ITDacute Myeloid Leukemia Patients: Which Should We Trust as a Minimal Residual Disease Marker?

American Journal of Hematology
Hematology
2017English

Should We Consider Non-Compliance a Medical Error?

Quality and Safety in Health Care
2002English

Retinal Thinning as a Marker of Disease Progression in Patients With Wolfram Syndrome

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Arginase Activity - A Marker of Disease Status in Patients With Visceral Leishmaniasis in Ethiopia

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2013English

A Transcultural Cognitive Marker of Alzheimer's Disease

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy